NCT07137299

Brief Summary

The goal of this observational study is to evaluate the impact of different hysterectomy (removal of the uterus) techniques on the risk of pelvic organ prolapse (situation when one or more of your pelvic organs like your bladder, uterus, or rectum have dropped down or slipped out of their normal position, sometimes even bulging into the vagina) and urinary incontinence (leaking urine unexpectedly) in women aged 18-85 who underwent hysterectomy or supracervical hysterectomy (removing of the uterus without its cervix) for benign (not cancer) conditions. The main question is: to check how different surgical technique (laparoscopic, with opening the abdomen, vaginal and robotic) increase the risk of pelvic organ prolapse or urinary incontinence There is no randomization or control group; comparisons will be made between surgery types based on clinical and questionnaire data. Participants will:

  • Receive an invitation to participate if they underwent hysterectomy between 2021-2025.
  • Fill out validated quality of life questionnaires (P-QOL, POPDI-6, PFIQ-7) every two years.
  • Attend follow-up clinical pelvic exams every two years to assess vaginal cuff healing, pelvic organ prolapses (POP-Q system), and urinary symptoms. This prospective, non-commercial, multicenter study plans to enroll 2,000 women and will run from July 1, 2025, to July 1, 2036

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2,000

participants targeted

Target at P75+ for all trials

Timeline
136mo left

Started Oct 2025

Longer than P75 for all trials

Geographic Reach
1 country

4 active sites

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress5%
Oct 2025Jul 2037

First Submitted

Initial submission to the registry

August 2, 2025

Completed
20 days until next milestone

First Posted

Study publicly available on registry

August 22, 2025

Completed
1 month until next milestone

Study Start

First participant enrolled

October 1, 2025

Completed
10.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2036

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2037

Last Updated

August 22, 2025

Status Verified

August 1, 2025

Enrollment Period

10.8 years

First QC Date

August 2, 2025

Last Update Submit

August 15, 2025

Conditions

Keywords

HysterectomyVaginal hysterectomyLaparotomyLaparoscopyRobotic surgerypelvic organ prolapse

Outcome Measures

Primary Outcomes (3)

  • Assessment of the impact of different types of hysterectomy/uterine amputation on the incidence of urinary incontinence

    Ingelmann-Sundberg scale for symptoms of stress urinary incontinence. The Ingelmann-Sundberg scale is a grading system used to assess the severity of stress urinary incontinence (SUI). It categorizes SUI based on the degree of physical activity that provokes urine leakage. The scale has three grades, with Grade I being the mildest and Grade III the most severe. Grade I - Urine leakage occurs with a relevant increase in abdominal pressure, such as during coughing, sneezing, or laughing. Grade II - Urine leakage occurs with a lesser increase in abdominal pressure, such as during activities like running, picking up objects from the floor, or walking. Grade III - Urine leakage occurs with minimal physical exertion, such as during walking, stair climbing, or even while standing or lying down. The assessment is based on medical interview with the patient performed during clinical visit.

    At baseline and at 2-year intervals (Year 2, Year 4, Year 6, Year 8, and Year 10) through study completion; on average of 10 years.

  • Assessment of the impact of different types of hysterectomy/uterine amputation on the incidence of overactive bladder.

    OABSS Overactive Bladder Symptom Score (OABSS) was used to assess symptoms of overactive bladder. The scale consists of 7 questions on a five-point Likert scale that refer to every symptom of OAB: 1 for nocturia, 1 for urinary frequency, 3 for urgency, 1 for urge incontinence, and 1 generic question about bladder control. The total result is scored from 0 to 28, with patients with higher scores reporting worse symptoms.

    At baseline and at 2-year intervals (Year 2, Year 4, Year 6, Year 8, and Year 10) through study completion; on average of 10 years.

  • Assessment of the impact of different types of hysterectomy/uterine amputation on the incidence of pelvic organ prolapse

    POPQ - Pelvic Organ Prolapse-Quantification. The assessment is based on gynecological examination. The system measures the position of the most distal portion of the prolapse to the hymen level. 5 stages are described: * Stage 0: No prolapse * Stage I: Most distal prolapse is more than 1 cm above the hymen * Stage II: Most distal prolapse is between 1 cm above and 1 cm below the hymen * Stage III: Most distal prolapse is more than 1 cm below hymen but 2 cm shorter than total vaginal length * Stage IV: Complete eversion

    At baseline and at 2-year intervals (Year 2, Year 4, Year 6, Year 8, and Year 10) through study completion; on average of 10 years.

Secondary Outcomes (4)

  • Complications

    up to 30 days postoperatively

  • Assessment of the impact of different types of hysterectomy/uterine amputation on quality of life - by using P-QOL

    At baseline and at 2-year intervals (Year 2, Year 4, Year 6, Year 8, and Year 10) through study completion; on average of 10 years.

  • Assessment of the impact of different types of hysterectomy/uterine amputation on quality of life - by using POPDI-6

    At baseline and at 2-year intervals (Year 2, Year 4, Year 6, Year 8, and Year 10) through study completion; on average of 10 years.

  • Assessment of the impact of different types of hysterectomy/uterine amputation on quality of life - by using PFIQ-7

    At baseline and at 2-year intervals (Year 2, Year 4, Year 6, Year 8, and Year 10) through study completion; on average of 10 years.

Study Arms (6)

Lap-hyst

Women who underwent laparoscopic hysterectomy for benign conditions

Other: Questionnaire and Physical Exam

Robot-hyst

Women who underwent robotic hysterectomy for benign conditions

Other: Questionnaire and Physical Exam

Vaginal-Hyst

Women who underwent vaginal hysterectomy for benign conditions

Other: Questionnaire and Physical Exam

Abdom-Hyst

Women who underwent abdominal hysterectomy for benign conditions

Other: Questionnaire and Physical Exam

SAH

Women who underwent supracervical abdominal hysterectomy for benign conditions

Other: Questionnaire and Physical Exam

LASH

Women who underwent Laparoscopic Assisted Supracervical Hysterectomy for benign conditions

Other: Questionnaire and Physical Exam

Interventions

All study participants will be evaluated to assess: * Healing of the vaginal stump in the case of a total hysterectomy (normal/abnormal), * Symptoms of stress urinary incontinence (Ingelmann-Sundber scale, where 0 - no symptoms, Grade I - symptoms with coughing, pressure on the suprapubic area, laughing, or strenuous exertion, Grade II - loss of urine when levering, running, or climbing stairs, Grade III - loss of urine when lying down or standing without physical exertion) * Symptoms of an overactive bladder - present, absent * Symptoms of prolapse in the anterior and posterior compartments (assessed based on the POPQ scale) with an assessment of the defect site based on the de Lancey classification The examination will be performed by or with the assistance of a specialist in obstetrics and gynecology

Abdom-HystLASHLap-hystRobot-hystSAHVaginal-Hyst

Eligibility Criteria

Age18 Years - 85 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All women operated in selected time-frame in study centers for benign conditions

You may qualify if:

  • persons who underwent total or subtotal hysterectomy for benign conditions regardless of the type of surgery
  • agree to participate and to follow-up

You may not qualify if:

  • having uterus
  • health state - ECOG \>2
  • pelvic organ prolapse prior to the surgery
  • surgery due to malignant conditions (ovarian, cervical or endometrial cancer)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

Department of Gynaecology, Obstetrics and Gynaecological Oncology, University Clinical Centre, Medical University of Silesia

Katowice, Silesian Voivodeship, 40-752, Poland

Location

Department of Obstetrics and Gynecology, Szpital Zakonu Bonifratrów pw. Aniołów Stróżów

Katowice, Poland

Location

Department of Gynecology and Obstetrics, Medical University of Warsaw

Warsaw, Poland

Location

Department of Gynecology and Obstetrics, Szpital Bielański

Warsaw, Poland

Location

MeSH Terms

Conditions

LeiomyomaEndometrial HyperplasiaPelvic Organ Prolapse

Interventions

Surveys and QuestionnairesRestraint, Physical

Condition Hierarchy (Ancestors)

Neoplasms, Muscle TissueNeoplasms, Connective and Soft TissueNeoplasms by Histologic TypeNeoplasmsUterine DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital DiseasesProlapsePathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public HealthBehavior ControlTherapeuticsImmobilization

Central Study Contacts

Krzysztof Nowosielski, professor

CONTACT

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Target Duration
10 Years
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prof.

Study Record Dates

First Submitted

August 2, 2025

First Posted

August 22, 2025

Study Start

October 1, 2025

Primary Completion (Estimated)

July 1, 2036

Study Completion (Estimated)

July 1, 2037

Last Updated

August 22, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will share

Anonymized data (all) will be shared on request

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR
Time Frame
01.07.2026 - indefinitely
Access Criteria
All academic researches on request

Locations